Back to all Entrepreneurs

Nikolaos Mellios

Circular Genomics
Circular Genomics
2024
Year Selected

Albuquerque, NM, USA
Location(s)

Follow Nikolaos Mellios on LinkedIn

Pioneering Precision Medicine in Mental Health 

Nikolaos Mellios is the Co-founder and Chief Scientific Officer of Circular Genomics (Scale Up Cohort 8), a pioneering biotech company in precision psychiatric and neurological medicine, focused on using circular RNA biomarkers to enhance mental health diagnostics and treatment. 

With over 20 years of experience in RNA biology and neurological disease research, Nikolaos has become a leading expert in circRNA neuroscience. His academic journey includes significant roles as a Research Scientist and Postdoctoral Fellow at the Massachusetts Institute of Technology (MIT) and a tenure as an Associate Professor at the University of New Mexico’s Department of Neurosciences. In addition to his successful career, Nikolaos holds a PhD in Neuroscience from UMass Chan Medical School and a medical degree from the University of Athens. Through his work at Circular Genomics, Nikolaos is advancing the frontier of precision medicine in mental health, bringing data-driven solutions to psychiatric and neurological care.

Programs


Scale Up Program
Circular GenomicsCo-founder and CSO of Circular Genomics

Year Founded

2021

Year Selected

2024

Stage

Early Growth (Series A, Series B)

Team Size

1-20

Total Capital Raised

$12,800,000

Healthcare & Life Sciences

Relevant Resources

See All

Endeavor Greece selects Scale Up Cohort 8

Dec 18, 2024
Blog